|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
1 The Department of Clinical Research, Hoffmann-La Roche, Inc., Nutley, New Jersey.
2 The Aeromedical Research Unit, Yale University School of Medicine, New Haven, Connecticut.
Macacus rhesus monkeys tolerate isonicotinylhydrazine and its glucosyl and isopropyl derivatives administered serially over prolonged periods and in doses sufficiently high to expect a possible antituberculous activity.
Submitted on January 19, 1952
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |